Oxford Immunotec - U.S. Laboratory Services Business

Oxford Immunotec (NASDAQ:OXFD) is a global diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions. T-SPOT is their platform technology, designed to examine a patient's cellular immune response to infection; a product to come from this platform is the T-SPOT.TB Test, which is used to test for tuberculosis infection. Another product line is a range of assays for tick-borne diseases, such as Lyme disease, obtained through th...Show all

Oxford Immunotec (NASDAQ:OXFD) is a global diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions. T-SPOT is their platform technology, designed to examine a patient's cellula...Show all

Company (Acquired)

All investors data 0 Investors

Competitors

Patents